Subscribe to RSS
DOI: 10.1055/s-0031-1297925
New Insights into the HCV Quasispecies and Compartmentalization
Publication History
Publication Date:
21 December 2011 (online)

ABSTRACT
Hepatitis C virus (HCV) is a hepatotropic RNA virus with an extraordinary propensity to persist in the vast majority of infected individuals. During replication, because of the inherent infidelity of the viral RNA polymerase, each progeny RNA genome contains mutations that lead to a continuous diversification of the viral population. Consequently, HCV circulates in vivo as a quasispecies, which is a dynamic distribution of divergent but closely related genomes subjected to a continuous process of genetic variation, competition, and selection. This genomic heterogeneity confers a remarkable advantage to the viral population allowing for a rapid adaptation to a changing environment when the virus is subject to selective constraints exerted by the host, such as antiviral immunity, or external to the host, such as antiviral therapy. The large reservoir of variants provided by the quasispecies represents a great challenge for the control of HCV infection and has important biologic implications for viral persistence, host cell tropism, antiviral drug resistance, and development of an HCV vaccine. This review discusses the molecular mechanisms of HCV genetic variation and the biologic and clinical relevance of the quasispecies nature of HCV.
KEYWORDS
Hepatitis C virus - quasispecies - compartmentalism - immune escape - viral persistence
REFERENCES
- 1
Domingo E, Sabo D, Taniguchi T, Weissmann C.
Nucleotide sequence heterogeneity of an RNA phage population.
Cell.
1978;
13
(4)
735-744
MissingFormLabel
- 2
Domingo E, Wain-Hobson S.
The 30th anniversary of quasispecies. Meeting on ‘Quasispecies: past, present and
future’.
EMBO Rep.
2009;
10
(5)
444-448
MissingFormLabel
- 3
Eigen M.
Selforganization of matter and the evolution of biological macromolecules.
Naturwissenschaften.
1971;
58
(10)
465-523
MissingFormLabel
- 4 Eigen M, Schuster P. The Hypercycle. A Principle of Natural Self-Organization. Berlin: Springer-Verlag; 1979
MissingFormLabel
- 5 Houghton M. Hepatitis C virus. In: Fields B N, Knipe D M, Howley P M, Chanock R H, eds. Fields Virology. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1996: 1035-1058
MissingFormLabel
- 6
Lindenbach B D, Rice C M.
Unravelling hepatitis C virus replication from genome to function.
Nature.
2005;
436
(7053)
933-938
MissingFormLabel
- 7
Branch A D, Stump D D, Gutierrez J A, Eng F, Walewski J L.
The hepatitis C virus alternate reading frame (ARF) and its family of novel products:
the alternate reading frame protein/F-protein, the double-frameshift protein, and
others.
Semin Liver Dis.
2005;
25
(1)
105-117
MissingFormLabel
- 8
Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S.
Rapid evolution of RNA genomes.
Science.
1982;
215
(4540)
1577-1585
MissingFormLabel
- 9 Domingo E. Virus evolution. In: Knipe D M, Howley P F, eds. Fields Virology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007: 389-421
MissingFormLabel
- 10
Duffy S, Shackelton L A, Holmes E C.
Rates of evolutionary change in viruses: patterns and determinants.
Nat Rev Genet.
2008;
9
(4)
267-276
MissingFormLabel
- 11
Holland J J, Domingo E, de la Torre J C, Steinhauer D A.
Mutation frequencies at defined single codon sites in vesicular stomatitis virus and
poliovirus can be increased only slightly by chemical mutagenesis.
J Virol.
1990;
64
(8)
3960-3962
MissingFormLabel
- 12
Crotty S, Cameron C E, Andino R.
RNA virus error catastrophe: direct molecular test by using ribavirin.
Proc Natl Acad Sci U S A.
2001;
98
(12)
6895-6900
MissingFormLabel
- 13
Kalinina O, Norder H, Mukomolov S, Magnius L O.
A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.
J Virol.
2002;
76
(8)
4034-4043
MissingFormLabel
- 14
Yokoyama K, Takahashi M, Nishizawa T et al..
Identification and characterization of a natural inter-genotypic (2b/1b) recombinant
hepatitis C virus in Japan.
Arch Virol.
2011;
156
(9)
1591-1601
MissingFormLabel
- 15
Neumann A U, Lam N P, Dahari H et al..
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha
therapy.
Science.
1998;
282
(5386)
103-107
MissingFormLabel
- 16
Martell M, Esteban J I, Quer J et al..
Hepatitis C virus (HCV) circulates as a population of different but closely related
genomes: quasispecies nature of HCV genome distribution.
J Virol.
1992;
66
(5)
3225-3229
MissingFormLabel
- 17
de la Torre J C, Holland J J.
RNA virus quasispecies populations can suppress vastly superior mutant progeny.
J Virol.
1990;
64
(12)
6278-6281
MissingFormLabel
- 18
Domingo E, Martin V, Perales C et al..
Viruses as quasispecies: biological implications.
Curr Top Microbiol Immunol.
2006;
299
51-82
MissingFormLabel
- 19
Domingo E, Holland J J.
RNA virus mutations and fitness for survival.
Annu Rev Microbiol.
1997;
51
151-178
MissingFormLabel
- 20
Ruiz-Jarabo C M, Arias A, Baranowski E, Escarmís C, Domingo E.
Memory in viral quasispecies.
J Virol.
2000;
74
(8)
3543-3547
MissingFormLabel
- 21 Eigen M, Biebricher C K. Sequence space and quasispecies distribution. In: Domingo E, Ahlquist P, Holland J J, eds. RNA Genetics. Vol. 3. Boca Raton, FL: CRC Press; 1988: 211-245
MissingFormLabel
- 22
Steinhauer D A, Holland J J.
Rapid evolution of RNA viruses.
Annu Rev Microbiol.
1987;
41
409-433
MissingFormLabel
- 23
Ogata N, Alter H J, Miller R H, Purcell R H.
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.
Proc Natl Acad Sci U S A.
1991;
88
(8)
3392-3396
MissingFormLabel
- 24
Okamoto H, Kojima M, Okada S et al..
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability
and stability.
Virology.
1992;
190
(2)
894-899
MissingFormLabel
- 25
Lu L, Nakano T, Orito E, Mizokami M, Robertson B H.
Evaluation of accumulation of hepatitis C virus mutations in a chronically infected
chimpanzee: comparison of the core, E1, HVR1, and NS5b regions.
J Virol.
2001;
75
(6)
3004-3009
MissingFormLabel
- 26
Farci P, Alter H J, Wong D et al..
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
N Engl J Med.
1991;
325
(2)
98-104
MissingFormLabel
- 27
Thimme R, Oldach D, Chang K M, Steiger C, Ray S C, Chisari F V.
Determinants of viral clearance and persistence during acute hepatitis C virus infection.
J Exp Med.
2001;
194
(10)
1395-1406
MissingFormLabel
- 28
Rehermann B.
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution
and coexistence.
J Clin Invest.
2009;
119
(7)
1745-1754
MissingFormLabel
- 29
Walker C M.
Adaptive immunity to the hepatitis C virus.
Adv Virus Res.
2010;
78
43-86
MissingFormLabel
- 30
Dahari H, Major M, Zhang X et al..
Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and
early blockage of virion production.
Gastroenterology.
2005;
128
(4)
1056-1066
MissingFormLabel
- 31
Su A I, Pezacki J P, Wodicka L et al..
Genomic analysis of the host response to hepatitis C virus infection.
Proc Natl Acad Sci U S A.
2002;
99
(24)
15669-15674
MissingFormLabel
- 32
Gale Jr M, Foy E M.
Evasion of intracellular host defence by hepatitis C virus.
Nature.
2005;
436
(7053)
939-945
MissingFormLabel
- 33
Thimme R, Bukh J, Spangenberg H C et al..
Viral and immunological determinants of hepatitis C virus clearance, persistence,
and disease.
Proc Natl Acad Sci U S A.
2002;
99
(24)
15661-15668
MissingFormLabel
- 34
Bertoletti A, Ferrari C.
Kinetics of the immune response during HBV and HCV infection.
Hepatology.
2003;
38
(1)
4-13
MissingFormLabel
- 35
Lohmann V, Körner F, Koch J, Herian U, Theilmann L, Bartenschlager R.
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
Science.
1999;
285
(5424)
110-113
MissingFormLabel
- 36
Lohmann V, Körner F, Dobierzewska A, Bartenschlager R.
Mutations in hepatitis C virus RNAs conferring cell culture adaptation.
J Virol.
2001;
75
(3)
1437-1449
MissingFormLabel
- 37
Blight K J, Kolykhalov A A, Rice C M.
Efficient initiation of HCV RNA replication in cell culture.
Science.
2000;
290
(5498)
1972-1974
MissingFormLabel
- 38
Smith D B, Mellor J, Jarvis L M The International HCV Collaborative Study Group et al.
Variation of the hepatitis C virus 5′ non-coding region: implications for secondary
structure, virus detection and typing.
J Gen Virol.
1995;
76
(Pt 7)
1749-1761
MissingFormLabel
- 39
Bukh J, Miller R H, Purcell R H.
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.
Semin Liver Dis.
1995;
15
(1)
41-63
MissingFormLabel
- 40
Bukh J, Pietschmann T, Lohmann V et al..
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells
prevent productive replication in chimpanzees.
Proc Natl Acad Sci U S A.
2002;
99
(22)
14416-14421
MissingFormLabel
- 41
Ray S C, Mao Q, Lanford R E et al..
Hypervariable region 1 sequence stability during hepatitis C virus replication in
chimpanzees.
J Virol.
2000;
74
(7)
3058-3066
MissingFormLabel
- 42
Prince A M, Pawlotsky J M, Soulier A et al..
Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic
infections.
J Viral Hepat.
2004;
11
(3)
236-242
MissingFormLabel
- 43
Bassett S E, Thomas D L, Brasky K M, Lanford R E.
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability
in hepatitis C virus-inoculated chimpanzees.
J Virol.
1999;
73
(2)
1118-1126
MissingFormLabel
- 44
Bukh J.
A critical role for the chimpanzee model in the study of hepatitis C.
Hepatology.
2004;
39
(6)
1469-1475
MissingFormLabel
- 45
Gómez J, Martell M, Quer J, Cabot B, Esteban J I.
Hepatitis C viral quasispecies.
J Viral Hepat.
1999;
6
(1)
3-16
MissingFormLabel
- 46
Forns X, Bukh J, Purcell R H, Emerson S U.
How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes
of hepatitis C virus during the cloning procedure.
Proc Natl Acad Sci U S A.
1997;
94
(25)
13909-13914
MissingFormLabel
- 47
Fishman S L, Branch A D.
The quasispecies nature and biological implications of the hepatitis C virus.
Infect Genet Evol.
2009;
9
(6)
1158-1167
MissingFormLabel
- 48
Verbinnen T, Van Marck H, Vandenbroucke I et al..
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under
protease inhibitor selection pressure by 454 deep sequencing.
J Virol.
2010;
84
(21)
11124-11133
MissingFormLabel
- 49
Hiraga N, Imamura M, Abe H et al..
Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone
in vivo.
Hepatology.
2011;
Epub ahead of print
MissingFormLabel
- 50
Wang G P, Sherrill-Mix S A, Chang K M, Quince C, Bushman F D.
Hepatitis C virus transmission bottlenecks analyzed by deep sequencing.
J Virol.
2010;
84
(12)
6218-6228
MissingFormLabel
- 51
Bull R A, Luciani F, McElroy K et al..
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.
PLoS Pathog.
2011;
7
(9)
e1002243
MissingFormLabel
- 52
Zinkernagel R M.
On natural and artificial vaccinations.
Annu Rev Immunol.
2003;
21
515-546
MissingFormLabel
- 53
Farci P, Alter H J, Wong D C et al..
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in
vitro neutralization.
Proc Natl Acad Sci U S A.
1994;
91
(16)
7792-7796
MissingFormLabel
- 54
Shimizu Y K, Hijikata M, Iwamoto A et al..
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization
escape mutant viruses.
J Virol.
1994;
68
(3)
1494-1500
MissingFormLabel
- 55
Farci P, Shimoda A, Wong D et al..
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against
the hypervariable region 1 of the envelope 2 protein.
Proc Natl Acad Sci U S A.
1996;
93
(26)
15394-15399
MissingFormLabel
- 56
Shimizu Y K, Igarashi H, Kiyohara T et al..
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable
region 1 of hepatitis C virus can prevent viral infection in cell cultures.
Virology.
1996;
223
(2)
409-412
MissingFormLabel
- 57
Weiner A J, Geysen H M, Christopherson C et al..
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein
variants: potential role in chronic HCV infections.
Proc Natl Acad Sci U S A.
1992;
89
(8)
3468-3472
MissingFormLabel
- 58
Zeisel M B, Fafi-Kremer S, Fofana I et al..
Neutralizing antibodies in hepatitis C virus infection.
World J Gastroenterol.
2007;
13
(36)
4824-4830
MissingFormLabel
- 59
Zibert A, Meisel H, Kraas W et al..
Early antibody response against hypervariable region 1 is associated with acute self-limiting
infections of hepatitis C virus.
Hepatology.
1997;
25
(5)
1245-1249
MissingFormLabel
- 60
Kumar U, Monjardino J, Thomas H C.
Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic
patient.
Gastroenterology.
1994;
106
(4)
1072-1075
MissingFormLabel
- 61
Booth J C, Kumar U, Webster D, Monjardino J, Thomas H C.
Comparison of the rate of sequence variation in the hypervariable region of E2/NS1
region of hepatitis C virus in normal and hypogammaglobulinemic patients.
Hepatology.
1998;
27
(1)
223-227
MissingFormLabel
- 62
Prince A M, Brotman B, Lee D H et al..
Significance of the anti-E2 response in self-limited and chronic hepatitis C virus
infections in chimpanzees and in humans.
J Infect Dis.
1999;
180
(4)
987-991
MissingFormLabel
- 63
Major M E, Dahari H, Mihalik K et al..
Hepatitis C virus kinetics and host responses associated with disease and outcome
of infection in chimpanzees.
Hepatology.
2004;
39
(6)
1709-1720
MissingFormLabel
- 64
Bartosch B, Dubuisson J, Cosset F L.
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope
protein complexes.
J Exp Med.
2003;
197
(5)
633-642
MissingFormLabel
- 65
Hsu M, Zhang J, Flint M et al..
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral
particles.
Proc Natl Acad Sci U S A.
2003;
100
(12)
7271-7276
MissingFormLabel
- 66
Baumert T F, Ito S, Wong D T, Liang T J.
Hepatitis C virus structural proteins assemble into viruslike particles in insect
cells.
J Virol.
1998;
72
(5)
3827-3836
MissingFormLabel
- 67
Wakita T, Pietschmann T, Kato T et al..
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
Nat Med.
2005;
11
(7)
791-796
MissingFormLabel
- 68
Lindenbach B D, Evans M J, Syder A J et al..
Complete replication of hepatitis C virus in cell culture.
Science.
2005;
309
(5734)
623-626
MissingFormLabel
- 69
Bartosch B, Bukh J, Meunier J C et al..
In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly
conserved neutralization epitopes.
Proc Natl Acad Sci U S A.
2003;
100
(24)
14199-14204
MissingFormLabel
- 70
Meunier J C, Engle R E, Faulk K et al..
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and
enhancement of infectivity by apolipoprotein C1.
Proc Natl Acad Sci U S A.
2005;
102
(12)
4560-4565
MissingFormLabel
- 71
Logvinoff C, Major M E, Oldach D et al..
Neutralizing antibody response during acute and chronic hepatitis C virus infection.
Proc Natl Acad Sci U S A.
2004;
101
(27)
10149-10154
MissingFormLabel
- 72
Meunier J C, Bukh J, Diaz G et al..
Neutralizing antibodies to HCV in perinatally infected children followed prospectively.
J Infect Dis.
2011;
204
(11)
1741-1745
MissingFormLabel
- 73
Pestka J M, Zeisel M B, Bläser E et al..
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source
outbreak of hepatitis C.
Proc Natl Acad Sci U S A.
2007;
104
(14)
6025-6030
MissingFormLabel
- 74
von Hahn T, Yoon J C, Alter H et al..
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses
during chronic infection in vivo.
Gastroenterology.
2007;
132
(2)
667-678
MissingFormLabel
- 75
Dowd K A, Netski D M, Wang X H, Cox A L, Ray S C.
Selection pressure from neutralizing antibodies drives sequence evolution during acute
infection with hepatitis C virus.
Gastroenterology.
2009;
136
(7)
2377-2386
MissingFormLabel
- 76
Lavillette D, Morice Y, Germanidis G et al..
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely
correlate with viral replication kinetics at the acute phase of hepatitis C virus
infection.
J Virol.
2005;
79
(10)
6023-6034
MissingFormLabel
- 77
Bukh J, Thimme R, Meunier J C et al..
Previously infected chimpanzees are not consistently protected against reinfection
or persistent infection after reexposure to the identical hepatitis C virus strain.
J Virol.
2008;
82
(16)
8183-8195
MissingFormLabel
- 78
Penin F, Combet C, Germanidis G, Frainais P O, Deléage G, Pawlotsky J M.
Conservation of the conformation and positive charges of hepatitis C virus E2 envelope
glycoprotein hypervariable region 1 points to a role in cell attachment.
J Virol.
2001;
75
(12)
5703-5710
MissingFormLabel
- 79
Vieyres G, Dubuisson J, Patel A H.
Characterization of antibody-mediated neutralization directed against the hypervariable
region 1 of hepatitis C virus E2 glycoprotein.
J Gen Virol.
2011;
92
(Pt 3)
494-506
MissingFormLabel
- 80
Prentoe J, Jensen T B, Meuleman P et al..
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains
of genotypes 1 to 6 and impairs virus neutralization.
J Virol.
2011;
85
(5)
2224-2234
MissingFormLabel
- 81
Forns X, Thimme R, Govindarajan S et al..
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein
is infectious and causes acute resolving or persistent infection in chimpanzees.
Proc Natl Acad Sci U S A.
2000;
97
(24)
13318-13323
MissingFormLabel
- 82
Bankwitz D, Steinmann E, Bitzegeio J et al..
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals
the CD81 binding site, and protects conserved neutralizing epitopes.
J Virol.
2010;
84
(11)
5751-5763
MissingFormLabel
- 83
Zolla-Pazner S, Cardozo T.
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus
vaccine design.
Nat Rev Immunol.
2010;
10
(7)
527-535
MissingFormLabel
- 84
Ray S C, Wang Y M, Laeyendecker O, Ticehurst J R, Villano S A, Thomas D L.
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia:
hypervariable region 1 as a decoy.
J Virol.
1999;
73
(4)
2938-2946
MissingFormLabel
- 85
Keck Z Y, Op De Beeck A, Hadlock K G et al..
Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes
with distinct properties and biological functions.
J Virol.
2004;
78
(17)
9224-9232
MissingFormLabel
- 86
Keck Z Y, Li S H, Xia J et al..
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape
from broadly neutralizing antibodies but compromise virus infectivity.
J Virol.
2009;
83
(12)
6149-6160
MissingFormLabel
- 87
Diepolder H M, Zachoval R, Hoffmann R M et al..
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in
viral clearance in acute hepatitis C virus infection.
Lancet.
1995;
346
(8981)
1006-1007
MissingFormLabel
- 88
Gerlach J T, Diepolder H M, Jung M C et al..
Recurrence of hepatitis C virus after loss of virus-specific CD4( + ) T-cell response
in acute hepatitis C.
Gastroenterology.
1999;
117
(4)
933-941
MissingFormLabel
- 89
Cooper S, Erickson A L, Adams E J et al..
Analysis of a successful immune response against hepatitis C virus.
Immunity.
1999;
10
(4)
439-449
MissingFormLabel
- 90
Lechner F, Wong D K, Dunbar P R et al..
Analysis of successful immune responses in persons infected with hepatitis C virus.
J Exp Med.
2000;
191
(9)
1499-1512
MissingFormLabel
- 91
Grakoui A, Shoukry N H, Woollard D J et al..
HCV persistence and immune evasion in the absence of memory T cell help.
Science.
2003;
302
(5645)
659-662
MissingFormLabel
- 92
Shoukry N H, Grakoui A, Houghton M et al..
Memory CD8 + T cells are required for protection from persistent hepatitis C virus
infection.
J Exp Med.
2003;
197
(12)
1645-1655
MissingFormLabel
- 93
Gottwein J M, Scheel T K, Callendret B et al..
Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a
(strain ED43): genetic analyses and in vivo pathogenesis studies.
J Virol.
2010;
84
(10)
5277-5293
MissingFormLabel
- 94
Klenerman P, Thimme R.
T cell responses in hepatitis C: the good, the bad and the unconventional.
Gut.
2011;
Epub ahead of print
MissingFormLabel
- 95
Bengsch B, Seigel B, Ruhl M et al..
Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8 + T cells
is linked to antigen recognition and T cell differentiation.
PLoS Pathog.
2010;
6
(6)
e1000947
MissingFormLabel
- 96
Neumann-Haefelin C, Thimme R.
Success and failure of virus-specific T cell responses in hepatitis C virus infection.
Dig Dis.
2011;
29
(4)
416-422
MissingFormLabel
- 97
Weiner A, Erickson A L, Kansopon J et al..
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence
of a cytotoxic T lymphocyte escape variant.
Proc Natl Acad Sci U S A.
1995;
92
(7)
2755-2759
MissingFormLabel
- 98
Erickson A L, Kimura Y, Igarashi S et al..
The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes
targeted by cytotoxic T lymphocytes.
Immunity.
2001;
15
(6)
883-895
MissingFormLabel
- 99
Chang K M, Rehermann B, McHutchison J G et al..
Immunological significance of cytotoxic T lymphocyte epitope variants in patients
chronically infected by the hepatitis C virus.
J Clin Invest.
1997;
100
(9)
2376-2385
MissingFormLabel
- 100
Timm J, Lauer G M, Kavanagh D G et al..
CD8 epitope escape and reversion in acute HCV infection.
J Exp Med.
2004;
200
(12)
1593-1604
MissingFormLabel
- 101
Bowen D G, Walker C M.
Mutational escape from CD8 + T cell immunity: HCV evolution, from chimpanzees to man.
J Exp Med.
2005;
201
(11)
1709-1714
MissingFormLabel
- 102
Cox A L, Mosbruger T, Mao Q et al..
Cellular immune selection with hepatitis C virus persistence in humans.
J Exp Med.
2005;
201
(11)
1741-1752
MissingFormLabel
- 103
Ray S C, Fanning L, Wang X H et al..
Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.
J Exp Med.
2005;
201
(11)
1753-1759
MissingFormLabel
- 104
Tsai S L, Chen Y M, Chen M H et al..
Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism
of chronicity.
Gastroenterology.
1998;
115
(4)
954-965
MissingFormLabel
- 105
Guglietta S, Garbuglia A R, Salichos L et al..
Impact of viral selected mutations on T cell mediated immunity in chronically evolving
and self limiting acute HCV infection.
Virology.
2009;
386
(2)
398-406
MissingFormLabel
- 106
Tester I, Smyk-Pearson S, Wang P et al..
Immune evasion versus recovery after acute hepatitis C virus infection from a shared
source.
J Exp Med.
2005;
201
(11)
1725-1731
MissingFormLabel
- 107
Fernandez J, Taylor D, Morhardt D R et al..
Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis
C virus clone is associated with a decrease in the viral amino acid substitution rate
and low levels of heterogeneity.
J Virol.
2004;
78
(18)
9782-9789
MissingFormLabel
- 108
Kuntzen T, Timm J, Berical A et al..
Viral sequence evolution in acute hepatitis C virus infection.
J Virol.
2007;
81
(21)
11658-11668
MissingFormLabel
- 109
Ruhl M, Knuschke T, Schewior K East German HCV Study Group et al.
CD8 + T-cell response promotes evolution of hepatitis C virus nonstructural proteins.
Gastroenterology.
2011;
140
(7)
2064-2073
MissingFormLabel
- 110
Neumann-Haefelin C, McKiernan S, Ward S et al..
Dominant influence of an HLA-B27 restricted CD8 + T cell response in mediating HCV
clearance and evolution.
Hepatology.
2006;
43
(3)
563-572
MissingFormLabel
- 111
Kim A Y, Kuntzen T, Timm J et al..
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation
of targeted epitopes.
Gastroenterology.
2011;
140
(2)
686-696, e1
MissingFormLabel
- 112
Cox A L, Mosbruger T, Lauer G M, Pardoll D, Thomas D L, Ray S C.
Comprehensive analyses of CD8 + T cell responses during longitudinal study of acute
human hepatitis C.
Hepatology.
2005;
42
(1)
104-112
MissingFormLabel
- 113
Neumann-Haefelin C, Timm J, Spangenberg H C et al..
Virological and immunological determinants of intrahepatic virus-specific CD8 + T-cell
failure in chronic hepatitis C virus infection.
Hepatology.
2008;
47
(6)
1824-1836
MissingFormLabel
- 114
Komatsu H, Lauer G, Pybus O G et al..
Do antiviral CD8 + T cells select hepatitis C virus escape mutants? Analysis in diverse
epitopes targeted by human intrahepatic CD8 + T lymphocytes.
J Viral Hepat.
2006;
13
(2)
121-130
MissingFormLabel
- 115
Uebelhoer L, Han J H, Callendret B et al..
Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance
of viral fitness.
PLoS Pathog.
2008;
4
(9)
e1000143
MissingFormLabel
- 116
Liu L, Fisher B E, Dowd K A, Astemborski J, Cox A L, Ray S C.
Acceleration of hepatitis C virus envelope evolution in humans is consistent with
progressive humoral immune selection during the transition from acute to chronic infection.
J Virol.
2010;
84
(10)
5067-5077
MissingFormLabel
- 117
Wang H, Eckels D D.
Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein
of hepatitis C virus have the potential for generating escape variants that may have
important consequences for T cell recognition.
J Immunol.
1999;
162
(7)
4177-4183
MissingFormLabel
- 118
Fleming V M, Harcourt G, Barnes E, Klenerman P.
Virological footprint of CD4 + T-cell responses during chronic hepatitis C virus infection.
J Gen Virol.
2010;
91
(Pt 6)
1396-1406
MissingFormLabel
- 119
Fuller M J, Shoukry N H, Gushima T et al..
Selection-driven immune escape is not a significant factor in the failure of CD4 T
cell responses in persistent hepatitis C virus infection.
Hepatology.
2010;
51
(2)
378-387
MissingFormLabel
- 120
Farci P, Quinti I, Farci S et al..
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected
children followed prospectively.
Proc Natl Acad Sci U S A.
2006;
103
(22)
8475-8480
MissingFormLabel
- 121
Farci P, Shimoda A, Coiana A et al..
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
Science.
2000;
288
(5464)
339-344
MissingFormLabel
- 122
Laskus T, Wilkinson J, Gallegos-Orozco J F et al..
Analysis of hepatitis C virus quasispecies transmission and evolution in patients
infected through blood transfusion.
Gastroenterology.
2004;
127
(3)
764-776
MissingFormLabel
- 123
Farci P, Strazzera R, Alter H J et al..
Early changes in hepatitis C viral quasispecies during interferon therapy predict
the therapeutic outcome.
Proc Natl Acad Sci U S A.
2002;
99
(5)
3081-3086
MissingFormLabel
- 124
Manzin A, Solforosi L, Debiaggi M et al..
Dominant role of host selective pressure in driving hepatitis C virus evolution in
perinatal infection.
J Virol.
2000;
74
(9)
4327-4334
MissingFormLabel
- 125
Urbani S, Amadei B, Cariani E et al..
The impairment of CD8 responses limits the selection of escape mutations in acute
hepatitis C virus infection.
J Immunol.
2005;
175
(11)
7519-7529
MissingFormLabel
- 126
Alter H J, Seeff L B.
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective
on long-term outcome.
Semin Liver Dis.
2000;
20
(1)
17-35
MissingFormLabel
- 127
Yeo A E, Ghany M, Conry-Cantilena C et al..
Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic
chronic hepatitis C virus carriers.
J Viral Hepat.
2001;
8
(4)
256-263
MissingFormLabel
- 128
Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K.
Degree of diversity of hepatitis C virus quasispecies and progression of liver disease.
Hepatology.
1994;
20
(5)
1144-1151
MissingFormLabel
- 129
Koizumi K, Enomoto N, Kurosaki M et al..
Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection
and its significance in interferon treatment.
Hepatology.
1995;
22
(1)
30-35
MissingFormLabel
- 130
Hayashi J, Kishihara Y, Yamaji K et al..
Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis
C virus infection.
Hepatology.
1997;
25
(3)
697-701
MissingFormLabel
- 131
Yuki N, Hayashi N, Moribe T et al..
Relation of disease activity during chronic hepatitis C infection to complexity of
hypervariable region 1 quasispecies.
Hepatology.
1997;
25
(2)
439-444
MissingFormLabel
- 132
Naito M, Hayashi N, Moribe T et al..
Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes
and patients with type C chronic liver disease.
Hepatology.
1995;
22
(2)
407-412
MissingFormLabel
- 133
López-Labrador F X, Ampurdanès S, Giménez-Barcons M et al..
Relationship of the genomic complexity of hepatitis C virus with liver disease severity
and response to interferon in patients with chronic HCV genotype 1b infection [correction
of interferon].
Hepatology.
1999;
29
(3)
897-903
MissingFormLabel
- 134
Leone F, Zylberberg H, Squadrito G et al..
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with
severity of liver disease, HCV type, viral load or duration of infection.
J Hepatol.
1998;
29
(5)
689-694
MissingFormLabel
- 135
Rothman A L, Morishima C, Bonkovsky H L HALT-C Trial Group et al.
Associations among clinical, immunological, and viral quasispecies measurements in
advanced chronic hepatitis C.
Hepatology.
2005;
41
(3)
617-625
MissingFormLabel
- 136
Sullivan D G, Bruden D, Deubner H et al..
Hepatitis C virus dynamics during natural infection are associated with long-term
histological outcome of chronic hepatitis C disease.
J Infect Dis.
2007;
196
(2)
239-248
MissingFormLabel
- 137
Izopet J, Rostaing L, Sandres K et al..
Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression
in renal transplant recipients.
J Infect Dis.
2000;
181
(3)
852-858
MissingFormLabel
- 138
Qin H, Shire N J, Keenan E D Multicenter Hemophilia Cohort Study Group et al.
HCV quasispecies evolution: association with progression to end-stage liver disease
in hemophiliacs infected with HCV or HCV/HIV.
Blood.
2005;
105
(2)
533-541
MissingFormLabel
- 139
Tagariello G, Gerotto M, Pontisso P et al..
Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients
with haemophilia.
Haemophilia.
2004;
10
(1)
81-86
MissingFormLabel
- 140
Wang X H, Netski D M, Astemborski J et al..
Progression of fibrosis during chronic hepatitis C is associated with rapid virus
evolution.
J Virol.
2007;
81
(12)
6513-6522
MissingFormLabel
- 141
Ramírez S, Pérez-Del-Pulgar S, Forns X.
Virology and pathogenesis of hepatitis C virus recurrence.
Liver Transpl.
2008;
14
(Suppl 2)
S27-S35
MissingFormLabel
- 142
Feliu A, Gay E, García-Retortillo M, Saiz J C, Forns X.
Evolution of hepatitis C virus quasispecies immediately following liver transplantation.
Liver Transpl.
2004;
10
(9)
1131-1139
MissingFormLabel
- 143
Gretch D R, Polyak S J, Wilson J J, Carithers Jr R L, Perkins J D, Corey L.
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and
asymptomatic liver transplant recipients.
J Virol.
1996;
70
(11)
7622-7631
MissingFormLabel
- 144
Sullivan D G, Wilson J J, Carithers Jr R L, Perkins J D, Gretch D R.
Multigene tracking of hepatitis C virus quasispecies after liver transplantation:
correlation of genetic diversification in the envelope region with asymptomatic or
mild disease patterns.
J Virol.
1998;
72
(12)
10036-10043
MissingFormLabel
- 145
Sánchez-Fueyo A, Giménez-Barcons M, Puig-Basagoiti F et al..
Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV)
on the histological severity of HCV recurrence after liver transplantation.
J Med Virol.
2001;
65
(2)
266-275
MissingFormLabel
- 146
Lyra A C, Fan X, Lang D M et al..
Evolution of hepatitis C viral quasispecies after liver transplantation.
Gastroenterology.
2002;
123
(5)
1485-1493
MissingFormLabel
- 147
Arenas J I, Gallegos-Orozco J F, Laskus T et al..
Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver
transplantation.
J Infect Dis.
2004;
189
(11)
2037-2046
MissingFormLabel
- 148
Li H, Sullivan D G, Feuerborn N et al..
Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.
Virology.
2010;
402
(2)
248-255
MissingFormLabel
- 149
Lerat H, Berby F, Trabaud M A et al..
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.
J Clin Invest.
1996;
97
(3)
845-851
MissingFormLabel
- 150
Radkowski M, Wang L F, Vargas H E, Rakela J, Laskus T.
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after
orthotopic liver transplantation.
Transplantation.
1998;
66
(5)
664-666
MissingFormLabel
- 151
Laskus T, Radkowski M, Piasek A et al..
Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency
virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes.
J Infect Dis.
2000;
181
(2)
442-448
MissingFormLabel
- 152
Radkowski M, Wilkinson J, Nowicki M et al..
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences
in the central nervous system: evidence of replication.
J Virol.
2002;
76
(2)
600-608
MissingFormLabel
- 153
Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J.
The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus
peripheral blood mononuclear cell-derived virus.
J Infect Dis.
2002;
185
(4)
417-421
MissingFormLabel
- 154
Ducoulombier D, Roque-Afonso A M, Di Liberto G et al..
Frequent compartmentalization of hepatitis C virus variants in circulating B cells
and monocytes.
Hepatology.
2004;
39
(3)
817-825
MissingFormLabel
- 155
Roque-Afonso A M, Ducoulombier D, Di Liberto G et al..
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral
blood mononuclear cells.
J Virol.
2005;
79
(10)
6349-6357
MissingFormLabel
- 156
Bagaglio S, Cinque P, Racca S et al..
Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and
cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients.
AIDS.
2005;
19
(Suppl 3)
S151-S165
MissingFormLabel
- 157
Pal S, Sullivan D G, Kim S et al..
Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications
of HCV lymphotropism.
Gastroenterology.
2006;
130
(4)
1107-1116
MissingFormLabel
- 158
Blackard J T, Hiasa Y, Smeaton L et al..
Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.
J Infect Dis.
2007;
195
(12)
1765-1773
MissingFormLabel
- 159
McGuinness P H, Bishop G A, McCaughan G W, Trowbridge R, Gowans E J.
False detection of negative-strand hepatitis C virus RNA.
Lancet.
1994;
343
(8896)
551-552
MissingFormLabel
- 160
Lanford R E, Chavez D, Chisari F V, Sureau C.
Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear
cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase
PCR.
J Virol.
1995;
69
(12)
8079-8083
MissingFormLabel
- 161
Laskus T, Radkowski M, Wang L F, Cianciara J, Vargas H, Rakela J.
Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear
cells and viral sequences are identical to those in serum: a case against extrahepatic
replication.
J Gen Virol.
1997;
78
(Pt 11)
2747-2750
MissingFormLabel
- 162
Quadri R, Rubbia-Brandt L, Abid K, Negro F.
Detection of the negative-strand hepatitis C virus RNA in tissues: implications for
pathogenesis.
Antiviral Res.
2001;
52
(2)
161-171
MissingFormLabel
- 163
Madejón A, Manzano M L, Arocena C, Castillo I, Carreño V.
Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus
RNA strands.
J Hepatol.
2000;
32
(6)
1019-1025
MissingFormLabel
- 164
Natarajan V, Kottilil S, Hazen A et al..
HCV in peripheral blood mononuclear cells are predominantly carried on the surface
of cells in HIV/HCV co-infected individuals.
J Med Virol.
2010;
82
(12)
2032-2037
MissingFormLabel
- 165
Pham T N, King D, Macparland S A et al..
Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis
C and occult infection.
Gastroenterology.
2008;
134
(3)
812-822
MissingFormLabel
- 166
Fujii K, Hino K, Okazaki M, Okuda M, Kondoh S, Okita K.
Differences in hypervariable region 1 quasispecies of hepatitis C virus between human
serum and peripheral blood mononuclear cells.
Biochem Biophys Res Commun.
1996;
225
(3)
771-776
MissingFormLabel
- 167
Cabot B, Esteban J I, Martell M et al..
Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not
be reflected by analysis of circulating HCV virions.
J Virol.
1997;
71
(2)
1732-1734
MissingFormLabel
- 168
Shimizu Y K, Igarashi H, Kanematu T et al..
Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and
peripheral blood mononuclear cells of infected chimpanzees.
J Virol.
1997;
71
(8)
5769-5773
MissingFormLabel
- 169
Maggi F, Fornai C, Vatteroni M L et al..
Differences in hepatitis C virus quasispecies composition between liver, peripheral
blood mononuclear cells and plasma.
J Gen Virol.
1997;
78
(Pt 7)
1521-1525
MissingFormLabel
- 170
Navas S, Martín J, Quiroga J A, Castillo I, Carreño V.
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome
in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.
J Virol.
1998;
72
(2)
1640-1646
MissingFormLabel
- 171
Maggi F, Fornai C, Morrica A et al..
Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear
cells of infected patients.
J Med Virol.
1999;
57
(1)
57-63
MissingFormLabel
- 172
Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K.
Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum,
peripheral blood mononuclear cells, and liver.
Hepatology.
1999;
29
(1)
217-222
MissingFormLabel
- 173
Fishman S L, Murray J M, Eng F J, Walewski J L, Morgello S, Branch A D.
Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.
J Infect Dis.
2008;
197
(4)
597-607
MissingFormLabel
- 174
Waddle D M.
Matrix correlation tests support a single origin for modern humans.
Nature.
1994;
368
(6470)
452-454
MissingFormLabel
- 175
Laskus T, Radkowski M, Bednarska A et al..
Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.
J Virol.
2002;
76
(19)
10064-10068
MissingFormLabel
- 176
Forton D M, Karayiannis P, Mahmud N, Taylor-Robinson S D, Thomas H C.
Identification of unique hepatitis C virus quasispecies in the central nervous system
and comparative analysis of internal translational efficiency of brain, liver, and
serum variants.
J Virol.
2004;
78
(10)
5170-5183
MissingFormLabel
- 177
Lerat H, Shimizu Y K, Lemon S M.
Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed
translation due to 5′ nontranslated region substitutions selected during passage of
virus in lymphoblastoid cells.
J Virol.
2000;
74
(15)
7024-7031
MissingFormLabel
- 178
Laporte J, Malet I, Andrieu T et al..
Comparative analysis of translation efficiencies of hepatitis C virus 5′ untranslated
regions among intraindividual quasispecies present in chronic infection: opposite
behaviors depending on cell type.
J Virol.
2000;
74
(22)
10827-10833
MissingFormLabel
- 179
Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, Cahour A.
Differential distribution and internal translation efficiency of hepatitis C virus
quasispecies present in dendritic and liver cells.
Blood.
2003;
101
(1)
52-57
MissingFormLabel
- 180
Di Liberto G, Roque-Afonso A M, Kara R et al..
Clinical and therapeutic implications of hepatitis C virus compartmentalization.
Gastroenterology.
2006;
131
(1)
76-84
MissingFormLabel
- 181
Ramirez S, Perez-Del-Pulgar S, Carrion J A et al..
Hepatitis C virus compartmentalization and infection recurrence after liver transplantation.
Am J Transplant.
2009;
9
(7)
1591-1601
MissingFormLabel
- 182
Kurosaki M, Enomoto N, Sakamoto N et al..
Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma
tissues.
J Hepatol.
1995;
22
(5)
527-535
MissingFormLabel
- 183
De Mitri M S, Mele L, Chen C H et al..
Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular
carcinoma.
J Hepatol.
1998;
29
(6)
887-892
MissingFormLabel
- 184
De Mitri M S, Cassini R, Bagaglio S et al..
Evolution of hepatitis C virus non-structural 5A gene in the progression of liver
disease to hepatocellular carcinoma.
Liver Int.
2007;
27
(8)
1126-1133
MissingFormLabel
- 185
Sobesky R, Feray C, Rimlinger F et al..
Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
Hepatology.
2007;
46
(6)
1704-1712
MissingFormLabel
- 186
Afdhal N H, McHutchison J G, Zeuzem S Pharmacogenetics and Hepatitis C Meeting Participants et al.
Hepatitis C pharmacogenetics: state of the art in 2010.
Hepatology.
2011;
53
(1)
336-345
MissingFormLabel
- 187
Ge D, Fellay J, Thompson A J et al..
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Nature.
2009;
461
(7262)
399-401
MissingFormLabel
- 188
Tanaka Y, Nishida N, Sugiyama M et al..
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin
therapy for chronic hepatitis C.
Nat Genet.
2009;
41
(10)
1105-1109
MissingFormLabel
- 189
Suppiah V, Moldovan M, Ahlenstiel G et al..
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin
therapy.
Nat Genet.
2009;
41
(10)
1100-1104
MissingFormLabel
- 190
Thomas D L, Thio C L, Martin M P et al..
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.
Nature.
2009;
461
(7265)
798-801
MissingFormLabel
- 191
Wohnsland A, Hofmann W P, Sarrazin C.
Viral determinants of resistance to treatment in patients with hepatitis C.
Clin Microbiol Rev.
2007;
20
(1)
23-38
MissingFormLabel
- 192
Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S.
The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis
C virus correlates with responsiveness to interferon therapy in viremic patients.
Hepatology.
1992;
16
(3)
619-624
MissingFormLabel
- 193
Kanazawa Y, Hayashi N, Mita E et al..
Influence of viral quasispecies on effectiveness of interferon therapy in chronic
hepatitis C patients.
Hepatology.
1994;
20
(5)
1121-1130
MissingFormLabel
- 194
Moribe T, Hayashi N, Kanazawa Y et al..
Hepatitis C viral complexity detected by single-strand conformation polymorphism and
response to interferon therapy.
Gastroenterology.
1995;
108
(3)
789-795
MissingFormLabel
- 195
Nagasaka A, Hige S, Tsunematsu I et al..
Changes in hepatitis C virus quasispecies and density populations in patients before
and after interferon therapy.
J Med Virol.
1996;
50
(3)
214-220
MissingFormLabel
- 196
Polyak S J, Faulkner G, Carithers Jr R L, Corey L, Gretch D R.
Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis:
correlation with response to interferon therapy.
J Infect Dis.
1997;
175
(5)
1101-1107
MissingFormLabel
- 197
Le Guen B, Squadrito G, Nalpas B et al..
Hepatitis C virus genome complexity correlates with response to interferon therapy:
a study in French patients with chronic hepatitis C.
Hepatology.
1997;
25
(5)
1250-1254
MissingFormLabel
- 198
Pawlotsky J M, Pellerin M, Bouvier M et al..
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV):
influence on the characteristics of the infection and responses to interferon alfa
therapy in patients with chronic hepatitis C.
J Med Virol.
1998;
54
(4)
256-264
MissingFormLabel
- 199
Hino K, Yamaguchi Y, Fujiwara D et al..
Hepatitis C virus quasispecies and response to interferon therapy in patients with
chronic hepatitis C: a prospective study.
J Viral Hepat.
2000;
7
(1)
36-42
MissingFormLabel
- 200
Chambers T J, Fan X, Droll D A et al..
Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during
pegylated interferon therapy of chronic hepatitis C virus infection.
J Virol.
2005;
79
(5)
3071-3083
MissingFormLabel
- 201
Morishima C, Polyak S J, Ray R Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group et al.
Hepatitis C virus-specific immune responses and quasi-species variability at baseline
are associated with nonresponse to antiviral therapy during advanced hepatitis C.
J Infect Dis.
2006;
193
(7)
931-940
MissingFormLabel
- 202
Torres-Puente M, Cuevas J M, Jiménez-Hernández N et al..
Genetic variability in hepatitis C virus and its role in antiviral treatment response.
J Viral Hepat.
2008;
15
(3)
188-199
MissingFormLabel
- 203
Moreau I, Levis J, Crosbie O, Kenny-Walsh E, Fanning L J.
Correlation between pre-treatment quasispecies complexity and treatment outcome in
chronic HCV genotype 3a.
Virol J.
2008;
5
78
MissingFormLabel
- 204
Saludes V, Bracho M A, Valero O et al..
Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected
patients by discriminant analysis using viral and host factors.
PLoS ONE.
2010;
5
(11)
e14132
MissingFormLabel
- 205
Nakazawa T, Kato N, Ohkoshi S, Shibuya A, Shimotohno K.
Characterization of the 5′ noncoding and structural region of the hepatitis C virus
genome from patients with non-A, non-B hepatitis responding differently to interferon
treatment.
J Hepatol.
1994;
20
(5)
623-629
MissingFormLabel
- 206
López-Labrador F X, Ampurdanès S, Giménez-Barcons M et al..
Relationship of the genomic complexity of hepatitis C virus with liver disease severity
and response to interferon in patients with chronic HCV genotype 1b infection [correction
of interferon].
Hepatology.
1999;
29
(3)
897-903
MissingFormLabel
- 207
Sandres K, Dubois M, Pasquier C et al..
Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome
and sensitivity of HCV to alpha interferon therapy.
J Virol.
2000;
74
(2)
661-668
MissingFormLabel
- 208
Fan X, Mao Q, Zhou D et al..
High diversity of hepatitis C viral quasispecies is associated with early virological
response in patients undergoing antiviral therapy.
Hepatology.
2009;
50
(6)
1765-1772
MissingFormLabel
- 209
Polyak S J, McArdle S, Liu S L et al..
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative
interferon sensitivity-determining region during interferon therapy and natural infection.
J Virol.
1998;
72
(5)
4288-4296
MissingFormLabel
- 210
Pawlotsky J M, Germanidis G, Frainais P O et al..
Evolution of the hepatitis C virus second envelope protein hypervariable region in
chronically infected patients receiving alpha interferon therapy.
J Virol.
1999;
73
(8)
6490-6499
MissingFormLabel
- 211
Abbate I, Lo Iacono O, Di Stefano R et al..
HVR-1 quasispecies modifications occur early and are correlated to initial but not
sustained response in HCV-infected patients treated with pegylated- or standard-interferon
and ribavirin.
J Hepatol.
2004;
40
(5)
831-836
MissingFormLabel
- 212
Sherman K E, Rouster S D, Stanford S AIDS Clinical Trials Group 5071 Study Team et al.
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected
subjects treated with interferon-based regimens.
J Infect Dis.
2010;
201
(5)
712-719
MissingFormLabel
- 213
Thelu M A, Baud M, Leroy V, Seigneurin J M, Zarski J P.
Dynamics of viral quasispecies during interferon therapy in non responder chronic
hepatitis C patients.
J Clin Virol.
2001;
22
(1)
125-131
MissingFormLabel
- 214
Enomoto N, Sakuma I, Asahina Y et al..
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis
C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in
the NS5A region.
J Clin Invest.
1995;
96
(1)
224-230
MissingFormLabel
- 215
Enomoto N, Sakuma I, Asahina Y et al..
Mutations in the nonstructural protein 5A gene and response to interferon in patients
with chronic hepatitis C virus 1b infection.
N Engl J Med.
1996;
334
(2)
77-81
MissingFormLabel
- 216
Sáiz J C, López-Labrador F X, Ampurdanés S et al..
The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining
region is different in infections with genotype 1b and 3a isolates of hepatitis C
virus.
J Infect Dis.
1998;
177
(4)
839-847
MissingFormLabel
- 217
Puig-Basagoiti F, Sáiz J C, Forns X et al..
Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis
C virus on the response to interferon therapy in chronic hepatitis C.
J Med Virol.
2001;
65
(1)
35-44
MissingFormLabel
- 218
Hayashi K, Katano Y, Honda T et al..
Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype
2a correlate with response to pegylated-interferon-alpha 2a monotherapy.
J Med Virol.
2009;
81
(3)
459-466
MissingFormLabel
- 219
Khorsi H, Castelain S, Wyseur A et al..
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict
the response to recombinant interferon-alfa therapy in French patients.
J Hepatol.
1997;
27
(1)
72-77
MissingFormLabel
- 220
Squadrito G, Leone F, Sartori M et al..
Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic
hepatitis C to interferon alfa.
Gastroenterology.
1997;
113
(2)
567-572
MissingFormLabel
- 221
Jardim A C, Yamasaki L H, de Queiróz A T et al..
Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon
and ribavirin.
Infect Genet Evol.
2009;
9
(4)
689-698
MissingFormLabel
- 222
Halfon P, Locarnini S.
Hepatitis C virus resistance to protease inhibitors.
J Hepatol.
2011;
55
(1)
192-206
MissingFormLabel
- 223
Wainberg M A, Zaharatos G J, Brenner B G.
Development of antiretroviral drug resistance.
N Engl J Med.
2011;
365
(7)
637-646
MissingFormLabel
- 224
Sarrazin C, Kieffer T L, Bartels D et al..
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with
the protease inhibitor telaprevir.
Gastroenterology.
2007;
132
(5)
1767-1777
MissingFormLabel
- 225
Bartels D J, Zhou Y, Zhang E Z et al..
Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A
protease inhibitors in treatment-naive subjects.
J Infect Dis.
2008;
198
(6)
800-807
MissingFormLabel
- 226
Kuntzen T, Timm J, Berical A et al..
Naturally occurring dominant resistance mutations to hepatitis C virus protease and
polymerase inhibitors in treatment-naïve patients.
Hepatology.
2008;
48
(6)
1769-1778
MissingFormLabel
- 227
Cubero M, Esteban J I, Otero T et al..
Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of
an untreated chronic hepatitis C patient.
Virology.
2008;
370
(2)
237-245
MissingFormLabel
- 228
Kim A Y, Timm J, Nolan B E et al..
Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive,
hepatitis C virus-infected individual.
J Infect Dis.
2009;
199
(5)
737-741
MissingFormLabel
- 229
Nijhuis M, van Maarseveen N M, Boucher C A.
Antiviral resistance and impact on viral replication capacity: evolution of viruses
under antiviral pressure occurs in three phases.
Handb Exp Pharmacol.
2009;
189
(189)
299-320
MissingFormLabel
- 230
Shimakami T, Welsch C, Yamane D et al..
Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired
production of infectious virus.
Gastroenterology.
2011;
140
(2)
667-675
MissingFormLabel
Patrizia Farci
National Institutes of Health, 50 South Drive, MSC 8009
Building 50, Room 6529, Bethesda, MD 20892
Email: pfarci@niaid.nih.gov